Immuneering Corporation (IMRX), a clinical-stage oncology company, Thursday said it has signed a clinical supply agreement with ...

Immuneering plans to evaluate IMM-1-104 in combination with Libtayo in patients with advanced non-small cell lung cancer in its ongoing Phase ...

Regeneron's Q4 earnings report shows revenue growth, stable EYLEA sales, dividend announcement, and impressive growth for ...

Regeneron stock jumped Tuesday after the biotech giant topped Wall Street's December-quarter calls on the back of its cancer drug Libtayo.

Keeping on top of the current and next Wuthering Waves banner is important for any Rover exploring this expansive, open-world ARPG from Kuro Games, and we’re here to help. With this in-depth guide, we ...

The Non-Food Pantry will be distributing cleaning and hygiene products from noon-2 p.m. Saturday, Jan. 25 at St. Andrew’s Episcopal Church, 520 E. Seminary St., Greencastle. A light lunch will ...

Sanofi’s cancer immunotherapy Libtayo (cemiplimab) has a third US indication after the FDA approved it for certain untreated lung cancer patients. The approval in first-line lung cancer ...

Sanofi and Regeneron’s checkpoint inhibitor Libtayo has become the first immunotherapy to improve survival when used as a second-line therapy in cervical cancer, setting up regulatory filings ...

HoYoverse has officially announced the complete banners and events schedule for Phase II of the ongoing Genshin Impact 5.3 update. The second half will feature the popular Lantern Rite event ...

LIBTAYO globally grew sales to $288.6M, a +23% YoY growth rate. While DUPIXENT sales grew to $3,817M, a +24% YoY growth rate. Importantly, data in the table below reflect net product sales ...

The Honkai Star Rail banner schedule provides plenty of useful information for players, as it confirms what warp events are currently in progress and shows the rewards you can unlock by ...

In the?US, the generic name for Libtayo in its approved?indications is cemiplimab-rwlc, with rwlc as the suffix designated in accordance with Nonproprietary Naming of Biological Products Guidance for ...